CME Opportunities: Coronavirus (COVID-19) Updates


Coronavirus

The Baylor College of Medicine Division of Continuing Professional Development has made educational activities available for all physicians.

Optimization of Health before Surgery: Lessons from the ACS Strong for Surgery Program and Rethinking Clinical Care Models during the Pandemic

In this session of the annual William D. Seybold Distinguished Lectureship, Dr. Thomas Varghese discusses the American College of Surgeon's Strong for Surgery Quality Improvement Program, including: design principles, lessons learned, and ways in which surgical care has been impacted by the COVID-19 pandemic.

Physicians who watch this presentation and complete a post-test and evaluation may be awarded a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

Helping Surgeons Go the Distance: Resilience, Leadership, and Career Longevity

In this presentation, Dr. Taylor Riall discusses the impact of a culture shift within academic medical centers to better promote the well-being of surgeons and learners. She highlights how a beneficial change in learning environment can help mitigate typical surgeon challenges, as well as those that are specific to working and learning during the COVID-19 pandemic.

Physicians who watch this presentation and complete a post-test and evaluation may be awarded a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

A Year in COVID-19 Therapeutics Development

This presentation is part of the COVID-19 Series. Dr. Robert Atmar and Dr. Hana El Sahly discuss primary elements of COVID-19 therapeutics development, including: therapeutic targets, antivirals, antibody-based treatments, and immune modulators.

Physicians who watch this presentation and complete a post-test and evaluation may be awarded a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

2020: Annus Horribilis, or Annus Mirabilis?

Dr. Jeffrey B. Matthews discusses the national state of surgical practice, and both personal and professional achievements and hardships in the face of challenging restrictions due to the 2020 COVID-19 pandemic. This 3rd Annual Michael E. DeBakey Distinguished Lecture, sponsored by the DeBakey Foundation, took place on Wednesday, December 9, 2020 at 7:00 A.M.

Physicians who watch this presentation and complete a post-test and evaluation may be awarded a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

Health Equity and COVID-19: My View from Philanthropy, Research, and Government

This presentation is part of the IDEA Series. Dr. Marcella Nunez-Smith discusses the challenges and achievements of her work in advocating for under-served populations during the COVID-19 pandemic. Dr. Nunez-Smith will serve as one of the co-chairs for President-Elect Biden’s Coronavirus Task Force.

Physicians who watch this presentation and complete a post-test and evaluation may be awarded a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

The Imperative for Self-Care and Resilience during a Crisis: Lessons from the COVID-19 Pandemic

This Department of Medicine Grand Rounds event took place on Thursday, September 24, 2020 at 12:15 P.M. and has been approved for ethics credit.

Physicians who watch this presentation and complete a post-test and evaluation may be awarded a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

Riding the First Wave of COVID-19 in New York City

This Department of Medicine Grand Rounds event took place on Thursday, September 3, 2020 at 12:15 P.M. Dr. Matthew McCarthy is an Assistant Professor of Medicine at Weill Cornell Medical College and a Staff Physician at New York Presbyterian Hospital, and he serves as a pandemic advisor to the U.S. Army. He was the first COVID-19 attending hospitalist at New York Presbyterian Hospital and was responsible for determining best practices and research protocols.

Physicians who watch this presentation and complete a post-test and evaluation may be awarded a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

COVID-19 Associated Coagulopathy and Antithrombotic Management

This Department of Medicine Grand Rounds session took place on Thursday, August 6, 2020 at 12:15 P.M.

Physicians who watch this presentation and complete a post-test and evaluation may be awarded a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

SARS-CoV2 and Hyper-Inflammatory ARDS - The New Kid on the Block

In this third presentation of the five-part Updates on COVID-19 series, Dr. Ivan Rosas, M.D. discusses acute respiratory distress syndrome (ARDS), effective interventions, and ARDS phenotypes. He then relates ARDS research and guidelines to the current coronavirus pandemic and the clinical management of COVID-19. He concludes by introducing COVACTA, a new study focusing on potential pharmacological treatment of patients with severe COVID pneumonia.

Physicians who watch this presentation and complete a post-test and evaluation may be awarded a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

COVID-19 Clinical Management: The Experts' Perspective

A panel of Baylor College of Medicine-affiliated experts share current evidence and trends in the clinical management of COVID-19. Dr. Laila Woc-Colburn, M.D. discusses the typical clinical presentation of the disease. Dr. Sergio Trevino Castillo, M.D. discusses intensive care management of COVID-19 pneumonia. Dr. Hana El Sahly, M.D. discusses antiviral treatment approaches, including recent data on remdesivir.

Physicians who watch this presentation and complete a post-test and evaluation may be awarded a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

In the Time of Covid-19: What We Should Know?

Dr. Laila Woc-Colburn, M.D., DTM&H discusses the epidemiology and projections of the Covid-19 pandemic, as well as clinical presentations and potential therapeutics. She shares current statistics and studies that have been recently published regarding cases of Covid-19. All information is current as of April 8, 2020, and is subject to change as the pandemic continues.

Physicians who watch this presentation and complete a post-test and evaluation may be awarded a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

2019 Coronavirus Disease (COVID-19): Overview and Current State of the Outbreak

In this presentation, Dr. Prathit Kulkarni, M.D. and Dr. Robert Atmar, M.D. discuss the emerging COVID-19 pandemic. Dr. Kulkarni gives background information on the outbreak and discusses transmission dynamics and clinical characteristics and outcomes of this disease. Dr. Atmar discusses the virology of the infection, potential therapeutic options, and possible vaccine development. Both physicians answer remote audience questions at the end of the presentation.

Physicians who watch this presentation and complete a post-test and evaluation may be awarded a maximum of 1.0 AMA PRA Category 1 Credit(s)™.